International Stem Cell Corporation (OTCPK:ISCO) announced a private placement of an unsecured, non-convertible 2021 promissory note for gross proceeds of $350,000 on March 5, 2021. The transaction included participation from returning investor Andrey Semechkin, Chief Executive Officer of the company. The note will mature on January 15, 2022 and will carry a fixed interest rate of 4.5% per annum. The note may be pre-paid by the company without penalty at any time.